Yuan Yuan
Yuan Yuan
Verified email at astrazeneca.com - Homepage
Cited by
Cited by
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ...
Nature genetics 45 (10), 1113-1120, 2013
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
Integrated genomic and molecular characterization of cervical cancer
Cancer Genome Atlas Research Network
Nature 543 (7645), 378, 2017
A community effort to assess and improve drug sensitivity prediction algorithms
JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ...
Nature biotechnology 32 (12), 1202, 2014
TANRIC: an interactive open platform to explore the function of lncRNAs in cancer
J Li, L Han, P Roebuck, L Diao, L Liu, Y Yuan, JN Weinstein, H Liang
Cancer research 75 (18), 3728-3737, 2015
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1
P Zhang, Y Wei, L Wang, BG Debeb, Y Yuan, J Zhang, J Yuan, M Wang, ...
Nature cell biology 16 (9), 864-875, 2014
The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers
L Han, L Diao, S Yu, X Xu, J Li, R Zhang, Y Yang, HMJ Werner, ...
Cancer cell 28 (4), 515-528, 2015
Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types
Y Yang, L Han, Y Yuan, J Li, N Hei, H Liang
Nature communications 5 (1), 1-9, 2014
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
Y Yuan, EM Van Allen, L Omberg, N Wagle, A Amin-Mansour, A Sokolov, ...
Nature biotechnology 32 (7), 644-652, 2014
A community computational challenge to predict the activity of pairs of compounds
M Bansal, J Yang, C Karan, MP Menden, JC Costello, H Tang, G Xiao, ...
Nature biotechnology 32 (12), 1213, 2014
Comprehensive characterization of molecular differences in cancer between male and female patients
Y Yuan, L Liu, H Chen, Y Wang, Y Xu, H Mao, J Li, GB Mills, Y Shu, L Li, ...
Cancer cell 29 (5), 711-722, 2016
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
P Zhang, L Wang, C Rodriguez-Aguayo, Y Yuan, BG Debeb, D Chen, ...
Nature communications 5 (1), 1-10, 2014
miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion
D Chen, Y Sun, Y Yuan, Z Han, P Zhang, J Zhang, MJ You, ...
PLoS genetics 10 (2), e1004177, 2014
The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes
L Han, Y Yuan, S Zheng, Y Yang, J Li, ME Edgerton, L Diao, Y Xu, ...
Nature communications 5 (1), 1-9, 2014
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers
Y Wang, X Xu, S Yu, KJ Jeong, Z Zhou, L Han, YH Tsang, J Li, H Chen, ...
Genome research 27 (7), 1112-1125, 2017
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas
L Omberg, K Ellrott, Y Yuan, C Kandoth, C Wong, MR Kellen, SH Friend, ...
Nature genetics 45 (10), 1121-1126, 2013
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
MP Griffin, Y Yuan, T Takas, JB Domachowske, SA Madhi, P Manzoni, ...
New England Journal of Medicine 383 (5), 415-425, 2020
Comprehensive molecular characterization of mitochondrial genomes in human cancers
Y Yuan, YS Ju, Y Kim, J Li, Y Wang, CJ Yoon, Y Yang, I Martincorena, ...
Nature genetics 52 (3), 342-352, 2020
Stochastic models for virus and immune system dynamics
Y Yuan, LJS Allen
Mathematical Biosciences, 2011
α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling
H Piao, Y Yuan, M Wang, Y Sun, H Liang, L Ma
Nature cell biology 16 (3), 245-254, 2014
The system can't perform the operation now. Try again later.
Articles 1–20